Investigational prostate cancer therapy (AstraZeneca)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational prostate cancer therapy (AstraZeneca), covering 2013-07-03 to 2013-07-03. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Prostate Cancer Study in Japanese Patients [Phase 1]